(Q24308741)

negative regulation of viral genome replication

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

Jin-Hai Chang

1

0 references

Naoya Kato

2

0 references

Ryosuke Muroyama

3

0 references

Hiroyoshi Taniguchi

4

0 references

Bayasi Guleng

5

0 references

Narayan Dharel

6

0 references

Run-Xuan Shao

7

0 references

Keisuke Tateishi

8

0 references

Amarsanaa Jazag

9

0 references

Takao Kawabe

10

0 references

Masao Omata

Structural biology of hepatitis C virus

11

0 references

language of work or name

English

0 references

publication date

February 2010

0 references

published in

Liver International

0 references

volume

30

0 references

page(s)

311-8

0 references

issue

2

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Hepatitis C virus expression and interferon antiviral action is dependent on PKR expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Antiviral therapy for chronic hepatitis C: past, present, and future

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Resolution of acute hepatitis C after therapy with natural beta interferon

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

The pathway of HCV IRES-mediated translation initiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Mechanistic Link between PKR Dimerization, Autophosphorylation, and eIF2α Substrate Recognition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Specific interaction of a 25-kilodalton cellular protein, a 40S ribosomal subunit protein, with the internal ribosome entry site of hepatitis C virus genome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

A mechanism for initiating RNA-dependent RNA polymerization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Induction of an interferon response by RNAi vectors in mammalian cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

The oncogenic potential of hepatitis C virus NS5A sequence variants is associated with PKR regulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

A ribonuclease specific for inosine-containing RNA: a potential role in antiviral defence?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

The dsRNA binding protein family: critical roles, diverse cellular functions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Complete replication of hepatitis C virus in cell culture

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Structural roles for human translation factor eIF3 in initiation of protein synthesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Replication of Hepatitis C Virus (HCV) RNA in Mouse Embryonic Fibroblasts: Protein Kinase R (PKR)-Dependent and PKR-Independent Mechanisms for Controlling HCV RNA Replication and Mediating Interferon Activities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021

The natural history of hepatitis C virus (HCV) infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2009.02144.X

7 January 2021